NASDAQ: UPB
Upstream Bio Inc Stock

$11.36-0.20 (-1.73%)
Updated Jun 13, 2025
UPB Price
$11.36
Fair Value Price
-$0.07
Market Cap
$611.10M
52 Week Low
$5.14
52 Week High
$29.46
P/E
N/A
P/B
1.37x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.02
Operating Cash Flow
N/A
Beta
1.16
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

UPB Overview

Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases that focuses on severe respiratory disorders. It develops verekitug, a monoclonal antibody that targets and inhibits the thymic stromal lymphopoietin receptor. The company also develops therapies to treat severe asthma, chronic rhinosinusitis with nasal polyps, and chronic obstructive pulmonary disease. Upstream Bio, Inc. was incorporated in 2021 and is based in Waltham, Massachusetts.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine UPB's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Biotech

Industry Rating
F
UPB
Ranked
#188 of 464

Top Ranked Stocks in Industry

View Top Biotech Stocks

Be the first to know about important UPB news, forecast changes, insider trades & much more!

UPB News

Overview

Due Diligence Score

Industry Average (24)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how UPB scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

UPB ($11.36) is overvalued by 16,655.92% relative to our estimate of its Fair Value price of -$0.07 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
UPB ($11.36) is not significantly undervalued (16,655.92%) relative to our estimate of its Fair Value price of -$0.07 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
UPB is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
There are 30 more UPB due diligence checks available for Premium users.

Valuation

UPB fair value

Fair Value of UPB stock based on Discounted Cash Flow (DCF)

Price
$11.36
Fair Value
-$0.07
Undervalued by
16,655.92%
UPB ($11.36) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
UPB ($11.36) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation

UPB price to earnings (PE)

For valuing profitable companies with steady earnings

Company
0x
Industry
-108.97x
Market
31.36x

UPB price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
1.37x
Industry
4.66x
UPB is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

UPB's financial health

Profit margin

Revenue
$566.0k
Net Income
-$27.3M
Profit Margin
-4,818%

Assets to liabilities

Assets
$456.2M
Liabilities
$10.6M
Debt to equity
0.02
UPB's short-term assets ($453.79M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
UPB's short-term assets ($453.79M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
UPB's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$41.2M
Investing
-$213.4M
Financing
-$34.0k

UPB vs Biotech Stocks

TickerZen RatingMarket Cap1d %P/EP/B
UPBC$611.10M-1.73%N/A1.37x
TRVIC$619.63M-1.30%-13.53x6.23x
EYPTD$621.37M+1.92%-3.73x2.08x
STOKC$629.50M-2.45%13.56x1.80x
BCAXD$591.17M-6.31%N/A1.29x

Upstream Bio Stock FAQ

What is Upstream Bio's quote symbol?

(NASDAQ: UPB) Upstream Bio trades on the NASDAQ under the ticker symbol UPB. Upstream Bio stock quotes can also be displayed as NASDAQ: UPB.

If you're new to stock investing, here's how to buy Upstream Bio stock.

What is the 52 week high and low for Upstream Bio (NASDAQ: UPB)?

(NASDAQ: UPB) Upstream Bio's 52-week high was $29.46, and its 52-week low was $5.14. It is currently -61.44% from its 52-week high and 121.01% from its 52-week low.

How much is Upstream Bio's stock price per share?

(NASDAQ: UPB) Upstream Bio stock price per share is $11.36 today (as of Jun 13, 2025).

What is Upstream Bio's Market Cap?

(NASDAQ: UPB) Upstream Bio's market cap is $611.10M, as of Jun 14, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Upstream Bio's market cap is calculated by multiplying UPB's current stock price of $11.36 by UPB's total outstanding shares of 53,793,703.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.